New Directions for Rabbit Antithymocyte Globulin (Thymoglobulin®) in Solid Organ Transplants, Stem Cell Transplants and Autoimmunity

Heart-Lung Transplantation

2016 • 2,165 citations

Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation

2007 • 1,692 citations

The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients

2010 • 1,528 citations

Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients

2011 • 1,321 citations

Lymphomas After Solid Organ Transplantation: A Collaborative Transplant Study Report

2004 • 1,061 citations

HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression

2008 • 935 citations

Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival

2013 • 784 citations

Rabbit Antithymocyte Globulin versus Basiliximab in Renal Transplantation

2006 • 695 citations

Human hand allograft: report on first 6 months

1999 • 684 citations

The Registry of the International Society for Heart and Lung Transplantation: 29th Adult Lung and Heart-Lung Transplant Report—2012

2012 • 610 citations

First human face allograft: early report

2006 • 610 citations

Cardiac Allograft Vasculopathy

2008 • 571 citations

Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation in Newly Diagnosed Type 1 Diabetes Mellitus

2007 • 560 citations

Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)

2001 • 511 citations

Tolerogenic immunosuppression for organ transplantation

2003 • 499 citations

Tolerance and Chimerism after Renal and Hematopoietic-Cell Transplantation

2008 • 494 citations

A Prospective, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial Comparing Early (7 Day) Corticosteroid Cessation Versus Long-Term, Low-Dose Corticosteroid Therapy

2008 • 454 citations

Horse versus Rabbit Antithymocyte Globulin in Acquired Aplastic Anemia

2011 • 453 citations

C-Peptide Levels and Insulin Independence Following Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation in Newly Diagnosed Type 1 Diabetes Mellitus

2009 • 433 citations

Posttransplant Lymphoproliferative Disorders after Renal Transplantation in the United States in Era of Modern Immunosuppression

2005 • 394 citations

A RANDOMIZED, DOUBLE-BLINDED COMPARISON OF THYMOGLOBULIN VERSUS ATGAM FOR INDUCTION IMMUNOSUPPRESSIVE THERAPY IN ADULT RENAL TRANSPLANT RECIPIENTS1,2

1999 • 373 citations

Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell–depleted SCT

2001 • 373 citations

Alemtuzumab Induction in Renal Transplantation

2011 • 358 citations

Thymoglobulin Prevents Chronic Graft-versus-Host Disease, Chronic Lung Dysfunction, and Late Transplant-Related Mortality: Long-Term Follow-Up of a Randomized Trial in Patients Undergoing Unrelated Donor Transplantation

2006 • 330 citations

Protective Conditioning for Acute Graft-versus-Host Disease

2005 • 324 citations

Complete Avoidance of Calcineurin Inhibitors in Renal Transplantation: A Randomized Trial Comparing Sirolimus and Tacrolimus

2006 • 301 citations

RESULTS OF THE DOUBLE-BLIND, RANDOMIZED, MULTICENTER, PHASE III CLINICAL TRIAL OF THYMOGLOBULIN VERSUS ATGAM IN THE TREATMENT OF ACUTE GRAFT REJECTION EPISODES AFTER RENAL TRANSPLANTATION1,2

1998 • 298 citations

Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation

2011 • 298 citations

Immunosuppression and the Risk of Post-Transplant Malignancy Among Cadaveric First Kidney Transplant Recipients

2003 • 295 citations

Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation1

2003 • 293 citations

MECHANISMS INVOLVED IN ANTITHYMOCYTE GLOBULIN IMMUNOSUPPRESSIVE ACTIVITY IN A NONHUMAN PRIMATE MODEL 1

2001 • 280 citations

The Decade of Polyomavirus BK-Associated Nephropathy: State of Affairs

2009 • 267 citations

Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.

1997 • 259 citations

Immunoprophylaxis with Basiliximab Compared with Antithymocyte Globulin in Renal Transplant Patients Receiving MMF-containing Triple Therapy

2002 • 251 citations

Donor-Specific Antibodies Adversely Affect Kidney Allograft Outcomes

2012 • 251 citations

A prospective, randomized, clinical trial of intraoperative versus postoperative thymoglobulin in adult cadaveric renal transplant recipients1

2003 • 245 citations

A Randomized Trial of Three Renal Transplant Induction Antibodies: Early Comparison of Tacrolimus, Mycophenolate Mofetil, and Steroid Dosing, and Newer Immune-Monitoring1

2005 • 218 citations

An OPTN Analysis of National Registry Data on Treatment of BK Virus Allograft Nephropathy in the United States

2009 • 217 citations

The ORION Study: Comparison of Two Sirolimus-Based Regimens versus Tacrolimus and Mycophenolate Mofetil in Renal Allograft Recipients

2011 • 211 citations

Dissociation of Depletional Induction and Posttransplant Lymphoproliferative Disease in Kidney Recipients Treated With Alemtuzumab

2007 • 208 citations

Everolimus Versus Mycophenolate Mofetil in Heart Transplantation: A Randomized, Multicenter Trial

2013 • 207 citations

Alloantibody Levels and Acute Humoral Rejection Early After Positive Crossmatch Kidney Transplantation

2008 • 207 citations

Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA working party

2010 • 205 citations

Immunosuppression with Belatacept-Based, Corticosteroid-Avoiding Regimens in De Novo Kidney Transplant Recipients

2010 • 196 citations

Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups

2012 • 192 citations

Daclizumab versus Antithymocyte Globulin in High-Immunological-Risk Renal Transplant Recipients

2009 • 190 citations

Sequential Protocols using Basiliximab versus Anti-Thymocyte Globulins in Renal-Transplant Patients Receiving Mycophenolate Mofetil and Steroids

2004 • 189 citations

Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin–based reduced-intensity preparative regimen

2003 • 188 citations

Epidemiology of Posttransplant Lymphoproliferative Disorders in Adult Kidney and Kidney Pancreas Recipients: Report of the French Registry and Analysis of Subgroups of Lymphomas

2012 • 187 citations

INDUCTION VERSUS NONINDUCTION IN RENAL TRANSPLANT RECIPIENTS WITH TACROLIMUS-BASED IMMUNOSUPPRESSION1

2001 • 185 citations

Tolerance and Withdrawal of Immunosuppressive Drugs in Patients Given Kidney and Hematopoietic Cell Transplants

2012 • 184 citations

Infectious Complications of Antilymphocyte Therapies in Solid Organ Transplantation

2009 • 182 citations

Bronchiolitis Obliterans Syndrome

2011 • 182 citations

Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens

2007 • 178 citations

Disassociation Between Risk of Graft Loss and Risk of Non-Hodgkin Lymphoma With Induction Agents in Renal Transplant Recipients

2006 • 171 citations

Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party

2012 • 169 citations

Prednisone‐Free Maintenance Immunosuppression—A 5‐Year Experience

2005 • 168 citations

Sirolimus Versus Cyclosporine in Kidney Recipients Receiving Thymoglobulin®, Mycophenolate Mofetil and a 6‐Month Course of Steroids

2007 • 166 citations

Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy1

2003 • 166 citations

Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti-thymocyte globulin

2006 • 166 citations

Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States

2009 • 165 citations

Impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune reconstitution and clinical outcome

2013 • 159 citations

First U.S. Near-Total Human Face Transplantation: A Paradigm Shift for Massive Complex Injuries

2009 • 159 citations

A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients1

2003 • 158 citations

Induction Immunosuppression Improves Long-Term Graft and Patient Outcome in Organ Transplantation: An Analysis of United Network for Organ Sharing Registry Data

2010 • 158 citations

BONE MARROW TRANSPLANT

2011 • 149 citations

A PROSPECTIVE STUDY OF RAPID CORTICOSTEROID ELIMINATION IN SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION

2002 • 146 citations

Full Face Transplant

2011 • 142 citations

Lymphoproliferative Disease after Renal Transplantation in Australia and New Zealand

2005 • 137 citations

Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation

1999 • 136 citations

Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: One-year results of a 2-center prospective randomized trial

2003 • 130 citations

Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy

2002 • 126 citations

Epidemiology of BK Virus in Renal Allograft Recipients: Independent Risk Factors for BK Virus Replication

2008 • 124 citations

SHORT COURSE INDUCTION IMMUNOSUPPRESSION WITH THYMOGLOBULIN FOR RENAL TRANSPLANT RECIPIENTS1

2002 • 122 citations

Risk Factors for BK Virus Infection in the Era of Therapeutic Drug Monitoring

2013 • 121 citations

Inferior Kidney Allograft Outcomes in Patients With De Novo Donor-Specific Antibodies Are Due to Acute Rejection Episodes

2011 • 119 citations

First Human Face Transplantation

2011 • 118 citations

Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: The evolution from myeloablative to lymphoablative transplant regimens

2006 • 116 citations

Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on cd3+ lymphocyte counts in kidney and kidney-pancreas transplant recipients

2002 • 115 citations

Evolution of the immunosuppressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial tolerance

2008 • 114 citations

STEROID-FREE IMMUNOSUPPRESSION IN RENAL TRANSPLANTATION

2001 • 110 citations

A Prospective Randomized Trial of Steroid-Free Maintenance Regimens in Kidney Transplant Recipients—An Interim Analysis

2005 • 106 citations

Rapid Discontinuation of Steroids in Living Donor Kidney Transplantation: A Pilot Study

2001 • 105 citations

Lower Risk of Infectious Deaths in Cardiac Transplant Patients Receiving Basiliximab Versus Anti-thymocyte Globulin as Induction Therapy

2007 • 104 citations

Graft-Versus-Host Disease After Intestinal and Multivisceral Transplantation

2010 • 104 citations

Rabbit Antithymocyte Globulin Decreases Acute Rejection After Lung Transplantation

1999 • 103 citations

Multicenter Australian Trial of Islet Transplantation: Improving Accessibility and Outcomes

2013 • 103 citations

Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia

2011 • 102 citations

A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper

2012 • 100 citations

A Comprehensive and Quantitative Analysis of the Major Specificities in Rabbit Antithymocyte Globulin Preparations

2013 • 98 citations

Alemtuzumab Induction Therapy in Kidney Transplantation

2012 • 97 citations

A useful scoring system for the prediction and management of delayed graft function following kidney transplantation from cadaveric donors

2014 • 96 citations

In vivo B-cell depletion with rituximab for alternative donor hemopoietic SCT

2011 • 93 citations

Comparison between horse and rabbit antithymocyte globulin as first-line treatment for patients with severe aplastic anemia: a single-center retrospective study

2010 • 91 citations

Reduced Incidence of Acute and Chronic Graft-versus-Host Disease with the Addition of Thymoglobulin to a Targeted Busulfan/Cyclophosphamide Regimen

2006 • 90 citations

Rabbit Antithymocyte Globulin (Thymoglobulin®)

2009 • 90 citations

COMPARISON OF SIROLIMUS-BASED CALCINEURIN INHIBITOR-SPARING AND CALCINEURIN INHIBITOR-FREE REGIMENS IN CADAVERIC RENAL TRANSPLANTATION

2004 • 88 citations

Association between pretransplant Thymoglobulin and reduced non-relapse mortality rate after marrow transplantation from unrelated donors

2002 • 87 citations

Short-term induction therapy with anti-thymocyte globulin and delayed use of calcineurin inhibitors in orthotopic liver transplantation

2007 • 87 citations

Atypical Acute Rejection After Hand Transplantation

2008 • 87 citations

Advantage of antithymocyte globulin induction in sensitized kidney recipients: a randomized prospective study comparing induction with and without antithymocyte globulin

1998 • 86 citations

Thymoglobulin and Its Use in Renal Transplantation: A Review

2013 • 82 citations

Thymoglobulin induction protects liver allografts from ischemia/reperfusion injury

2005 • 82 citations

Rabbit Antithymocyte Globulin (Thymoglobulin®)

2010 • 81 citations

Comparison of two dosages of thymoglobulin used as a short-course for induction in kidney transplantation

2006 • 79 citations

Vascularized composite tissue allotransplantation – state of the art

2013 • 79 citations

The impact of induction on survival after lung transplantation: an analysis of the International Society for Heart and Lung Transplantation Registry

2008 • 79 citations

Induction therapy by anti‐thymocyte globulin (rabbit) in renal transplantation: a 1‐yr follow‐up of safety and efficacy

2003 • 78 citations

The effect of low and ultra-low dosages Thymoglobulin on peripheral T, B and NK cells in kidney transplant recipients

2012 • 76 citations

In Kidney Transplant Patients, Alemtuzumab but Not Basiliximab/Low-Dose Rabbit Anti-Thymocyte Globulin Induces B Cell Depletion and Regeneration, Which Associates with a High Incidence of De Novo Donor-Specific Anti-HLA Antibody Development

2013 • 76 citations

A review of bronchiolitis obliterans syndrome and therapeutic strategies

2011 • 76 citations

Use of basiliximab and cyclosporine in heart transplant patients with pre-operative renal dysfunction

2005 • 76 citations

Novel approaches to the therapy of steroid-resistant acute graft-versus-host disease

2004 • 75 citations

Adult Recipients of Matched Related Donor Blood Cell Transplants Given Myeloablative Regimens Including Pretransplant Antithymocyte Globulin Have Lower Mortality Related to Graft-versus-Host Disease: A Matched Pair Analysis

2007 • 75 citations

Randomized study of 2 reduced‐intensity conditioning strategies for human leukocyte antigen‐matched, related allogeneic peripheral blood stem cell transplantation

2012 • 74 citations

Basiliximab and Rabbit Anti-thymocyte Globulin for Prophylaxis of Acute Rejection After Heart Transplantation: A Non-inferiority Trial

2007 • 72 citations

Thymoglobulin and ischemia reperfusion injury in kidney and liver transplantation

2007 • 71 citations

Antithymocyte Globulin Is Associated With a Lower Incidence of De Novo Donor-Specific Antibodies in Moderately Sensitized Renal Transplant Recipients

2014 • 71 citations

Randomized Trial of Single-Dose Versus Divided-Dose Rabbit Anti-Thymocyte Globulin Induction in Renal Transplantation: An Interim Report

2008 • 70 citations

A prospective, randomized, multicenter study evaluating early corticosteroid withdrawal with Thymoglobulin^® in living‐donor kidney transplantation

2009 • 68 citations

Safety and early outcomes using a corticosteroid-avoidance immunosuppression protocol in pediatric heart transplant recipients

2010 • 67 citations

Acute Rejection, T-Cell–Depleting Antibodies, and Cancer After Transplantation

2014 • 67 citations

A Randomized, Prospective, Pharmacoeconomic Trial of Tacrolimus versus Cyclosporine in Combination with Thymoglobulin in Renal Transplant Recipients

2005 • 66 citations

Vascularized composite allotransplantation: An update on medical and surgical progress and remaining challenges

2013 • 66 citations

Pretransplant identification of acute rejection risk following kidney transplantation

2013 • 64 citations

Risk for post‐transplant lymphoproliferative disorder after polyclonal antibody induction in kidney transplantation

2005 • 64 citations

LOW DOSE ANTITHYMOCYTE GLOBULINS IN RENAL TRANSPLANTATION

2000 • 64 citations

Early steroid withdrawal therapy in renal transplant recipients: a steroid‐free sirolimus and CellCept‐based calcineurin inhibitor‐minimization protocol

2006 • 63 citations

Immunosuppression induction with rabbit anti-thymocyte globulin with or without rituximab in 1000 liver transplant patients with long-term follow-up

2012 • 63 citations

Basiliximab Versus Rabbit Anti-thymocyte Globulin for Induction Therapy in Patients After Heart Transplantation

2006 • 63 citations

Unrelated donor BMT recipients given pretransplant low-dose antithymocyte globulin have outcomes equivalent to matched sibling BMT: a matched pair analysis

2002 • 62 citations

Induction Immunosuppression With Thymoglobulin and Rituximab in Intestinal and Multivisceral Transplantation

2008 • 62 citations

Promising early results with immunosuppression using rabbit anti-thymocyte globulin and steroids with delayed introduction of tacrolimus in adult liver transplant recipients

2004 • 62 citations

Impact of HLA Mismatching on Incidence of Posttransplant Non-Hodgkin Lymphoma After Kidney Transplantation

2010 • 60 citations

A randomized prospective study comparing low-dose OKT3 to low-dose ATG for the treatment of acute steroid-resistant rejection episodes in kidney transplant recipients

1998 • 60 citations

Early Outcomes of Thymoglobulin and Basiliximab Induction in Kidney Transplantation: Application of Statistical Approaches to Reduce Bias in Observational Comparisons

2009 • 59 citations

A 10-year experience with intravenous thymoglobuline in induction of immunosuppression following heart transplantation

1999 • 59 citations

A Randomized, Controlled Trial of Daclizumab vs Anti-thymocyte Globulin Induction for Lung Transplantation

2007 • 59 citations

Thymoglobulin Induction and Sirolimus Versus Tacrolimus in Kidney Transplant Recipients Receiving Mycophenolate Mofetil and Steroids

2010 • 59 citations

Thymoglobulin Induction Is Safe and Effective in Live-Donor Renal Transplantation: A Single Center Experience

2006 • 57 citations

Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplants

2009 • 55 citations

French Multicenter 22-Year Experience in Stem Cell Transplantation for Beta-Thalassemia Major: Lessons and Future Directions

2012 • 55 citations

Pediatric Kidney Transplantation Using a Novel Protocol of Rapid (6-Day) Discontinuation of Prednisone: 2-Year Results

2009 • 55 citations

Induction therapy after cardiac transplantation: A comparison of anti-thymocyte globulin and daclizumab in the prevention of acute rejection

2005 • 55 citations

Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5�years

2003 • 54 citations

Five-Year Results of a Randomized Trial Comparing De Novo Sirolimus and Cyclosporine in Renal Transplantation: The Spiesser Study

2012 • 54 citations

The role of <scp>T</scp>hymoglobulin induction in kidney transplantation: an update

2012 • 54 citations

Infection and malignancy after pediatric heart transplantation: The role of induction therapy

2010 • 54 citations

A high antithymocyte globulin dose increases the risk of relapse after reduced intensity conditioning <scp>HSCT</scp> with unrelated donors

2013 • 53 citations

Induction Therapy with Basiliximab versus Thymoglobulin in African-American Kidney Transplant Recipients

2005 • 53 citations

Thymoglobulin induction and steroid avoidance in cardiac transplantation: results of a prospective, randomized, controlled study

2007 • 52 citations

Immunological Issues in Clinical Composite Tissue Allotransplantation

2012 • 51 citations

Thymoglobulin induction in liver transplant recipients with a tacrolimus, mycophenolate mofetil, and steroid immunosuppressive regimen: A five-year randomized prospective study

2009 • 51 citations

Antithymocyte Globulin Induction Allows a Prolonged Delay in the Initiation of Cyclosporine in Heart Transplant Patients with Postoperative Renal Dysfunction

2004 • 50 citations

Rabbit Anti-thymocyte Globulin Induction Therapy Does Not Prolong Survival After Lung Transplantation

2008 • 50 citations

Transplantation from Matched Siblings Using Once-Daily Intravenous Busulfan/Fludarabine with Thymoglobulin: A Myeloablative Regimen with Low Nonrelapse Mortality in All But Older Patients with High-Risk Disease

2008 • 49 citations

Impact of polyclonal anti-thymocyte globulins on the expression of adhesion and inflammation molecules after ischemia–reperfusion injury

2008 • 49 citations

A pilot protocol of a calcineurin‐inhibitor free regimen for kidney transplant recipients of marginal donor kidneys or with delayed graft function

2003 • 49 citations

Randomized comparison of triple therapy and antithymocyte globulin induction treatment after simultaneous pancreas-kidney transplantation

1998 • 49 citations

Busulphan in Blood and Marrow Transplantation: Dose, Route, Frequency and Role of Therapeutic Drug Monitoring

2007 • 49 citations

Reduced intensity conditioning using intravenous busulfan, fludarabine and rabbit ATG for children with nonmalignant disorders and CML

2005 • 48 citations

Steroid Withdrawal for Pancreas after Kidney Transplantation in Recipients on Maintenance Prednisone Immunosuppression

2006 • 48 citations

Phase II study of rabbit anti-thymocyte globulin, cyclosporine and granulocyte colony-stimulating factor in patients with aplastic anemia and myelodysplastic syndrome

2009 • 47 citations

CMV infections after two doses of daclizumab versus thymoglobulin in renal transplant patients receiving mycophenolate mofetil, steroids and delayed cyclosporine A

2008 • 47 citations

Preferential increase in memory and regulatory subsets during T-lymphocyte immune reconstitution after Thymoglobulin induction therapy with maintenance sirolimus vs cyclosporine

2010 • 46 citations

Posttransplantation Lymphoproliferative Disorder in Kidney and Heart Transplant Recipients Receiving Thymoglobulin: A Systematic Review

2011 • 45 citations

Alemtuzumab as compared to alternative contemporary induction regimens

2012 • 45 citations

Total and Active Rabbit Antithymocyte Globulin (rATG;Thymoglobulin®) Pharmacokinetics in Pediatric Patients Undergoing Unrelated Donor Bone Marrow Transplantation

2009 • 44 citations

Outcome of induction immunosuppression for liver transplantation comparing anti-thymocyte globulin, daclizumab, and corticosteroid

2011 • 43 citations

Excellent clinical outcomes in primary kidney transplant recipients treated with steroid‐free maintenance immunosuppression

2006 • 43 citations

Thymoglobulin Versus ATGAM Induction Therapy in Pediatric Kidney Transplant Recipients: A Single-Center Report

2005 • 43 citations

Delayed Onset of Cardiac Allograft Vasculopathy by Induction Therapy Using Anti-thymocyte Globulin

2008 • 42 citations

Polyclonal anti-thymocyte globulins influence apoptosis in reperfused tissues after ischaemia in a non-human primate model

2004 • 42 citations

Short-Term Experience with Early Steroid Withdrawal in African-American Renal Transplant Recipients

2006 • 42 citations

Efficacy and Safety of Thymoglobulin Induction as an Alternative Approach for Steroid-Free Maintenance Immunosuppression in Pediatric Renal Transplantation

2010 • 41 citations

Preliminary Results of a “Prope” Tolerogenic Regimen with Thymoglobulin Pretreatment and Hepatitis C Virus Recurrence in Liver Transplantation

2005 • 41 citations

Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft

1998 • 41 citations

Thymoglobulin Versus Basiliximab Induction Therapy for Simultaneous Kidney-Pancreas Transplantation: Impact on Rejection, Graft Function, and Long-Term Outcome

2011 • 40 citations

CD3 monitoring of antithymocyte globulin therapy in thoracic organ transplantation

2002 • 40 citations

Successful Engraftment with Fludarabine, Cyclophosphamide, and Thymoglobulin Conditioning Regimen in Unrelated Transplantation for Severe Aplastic Anemia: A Phase II Prospective Multicenter Study

2010 • 39 citations

The Influence of Induction Therapy on Graft and Patient Survival in Patients with and without Hepatitis C after Liver Transplantation

2009 • 39 citations

Final results of the phase <scp>II</scp> study of rabbit anti‐thymocyte globulin, ciclosporin, methylprednisone, and granulocyte colony‐stimulating factor in patients with aplastic anaemia and myelodysplastic syndrome

2012 • 39 citations

Polyclonal anti-thymocyte globulins influence apoptosis in reperfused tissues after ischaemia in a non-human primate model

2004 • 38 citations

Induction Therapy With Thymoglobulin After Heart Transplantation: Impact of Therapy Duration on Lymphocyte Depletion and Recovery, Rejection, and Cytomegalovirus Infection Rates

2008 • 38 citations

Excellent Renal Allograft Survival in Donor-Specific Antibody Positive Transplant Patients—Role of Intravenous Immunoglobulin and Rabbit Antithymocyte Globulin

2009 • 38 citations

Antithymocyte globulin induction therapy for adult heart transplantation: A UK national study

2011 • 37 citations

A prospective-randomized controlled study on the efficacy and tolerance of two antilymphocytic globulins in the prevention of rejection in first-heart transplant recipients

2002 • 37 citations

A prospective randomized controlled study on the efficacy and tolerance of two antilymphocytic globulins in the prevention of rejection in first-heart transplant recipients.

2002 • 36 citations

Rapid Discontinuation of Prednisone in Higher-Risk Kidney Transplant Recipients

2004 • 36 citations

Induction therapy in heart transplantation: where are we now?

2013 • 35 citations

Antithymocyte Globulin Induction in Living Donor Renal Transplant Recipients

2012 • 33 citations

Review article: Use of induction therapy in liver transplantation

2012 • 33 citations

Islet transplantation in type I diabetes mellitus.

2012 • 33 citations

Induction Immunosuppression With Basiliximab in Heart Transplantation

2008 • 31 citations

BK virus replication following kidney transplant: Does the choice of immunosuppressive regimen influence outcomes?

2012 • 30 citations

Ten-year Follow-up of a Prospective, Randomized Trial of BT563/BB10 Versus Anti-thymocyte Globulin as Induction Therapy After Heart Transplantation

2006 • 30 citations

Intestinal and Multivisceral Transplantation Immunosuppression Protocols—Literature Review

2012 • 29 citations

Induction therapy in lung transplantation

2013 • 28 citations

Five years’ experience with thymoglobulin induction in a pediatric renal transplant population

2006 • 28 citations

A revised day +7 predictive score for transplant-related mortality: serum cholinesterase, total protein, blood urea nitrogen, γ glutamyl transferase, donor type and cell dose

2003 • 28 citations

Very early steroid withdrawal in simultaneous pancreas-kidney transplants

2006 • 28 citations

Randomized phase II trial comparing two dose levels of thymoglobulin in patients undergoing unrelated donor hematopoietic cell transplant

2011 • 27 citations

Alemtuzumab with Rapid Steroid Taper in Simultaneous Kidney and Pancreas Transplantation: Comparison to Induction with Antithymocyte Globulin

2010 • 27 citations

Multivariate Analysis of Antibody Induction Therapy and Their Associated Outcomes in Deceased Donor Transplants

2005 • 27 citations

Pharmacokinetic and pharmacodynamic studies of two different rabbit antithymocyte globulin dosing regimens: Results of a randomized trial

2013 • 27 citations

Experience with steroid-free maintenance immunosuppression in simultaneous pancreas-kidney transplantation

2004 • 27 citations

Simultaneous corticosteroid avoidance and calcineurin inhibitor minimization in renal transplantation

2006 • 27 citations

Crossmatch-Positive Liver Transplantation in Patients Receiving Thymoglobulin-Rituximab Induction

2013 • 26 citations

Induction antibody therapy in renal transplantation using early steroid withdrawal: Long-term results comparing anti-IL2 receptor and anti-thymocyte globulin

2011 • 26 citations

Effectivity of a T-Cell-Adapted Induction Therapy With Anti-Thymocyte Globulin (Sangstat)

2005 • 26 citations

Prevention of acute rejection with antithymocyte globulin, avoiding corticosteroids, and delaying cyclosporin after renal transplantation

2000 • 26 citations

CD3 monitoring and thymoglobulin therapy in cardiac transplantation: Clinical outcomes and pharmacoeconomic implications

2004 • 26 citations

Treatment of Autoimmune Disease with Rabbit Anti‐T Lymphocyte Globulin

2007 • 26 citations

Comparison of polyclonal induction agents in pediatric renal transplantation

2001 • 25 citations

Outcome and Cost Analysis of Induction Immunosuppression With IL2Mab or ATG in DCD Kidney Transplants

2014 • 25 citations

Low-Dose Thymoglobulin Use in Elderly Renal Transplant Recipients Is Safe and Effective Induction Therapy

2011 • 25 citations

Use of thymoglobulin induction therapy in the prevention of acute graft rejection episodes following liver transplantation

1997 • 24 citations

Could steroids be withdrawn in renal transplant patients sequentially treated with ATG, cyclosporine, and cellcept? One-year results of a double-blind, randomized, multicenter study comparing normal dose versus low-dose and withdrawal of steroids

2000 • 24 citations

Acute Rejection Risk in Kidney Transplant Recipients on Steroid-Avoidance Immunosuppression Receiving Induction With Either Antithymocyte Globulin or Basiliximab

2006 • 24 citations

Ursodeoxycholic acid increased bile flow and affects bile composition in the early postoperative phase following liver transplantation

1998 • 23 citations

Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin

1997 • 22 citations

Update on infectious complications following lung transplantation

2011 • 22 citations

Risk factors for impaired<scp>CD</scp>4⁺T‐cell reconstitution following rabbit antithymocyte globulin treatment in kidney transplantation

2013 • 21 citations

Obesity in Renal Transplantation: The Role of Induction Therapy on Long-Term Outcomes

2011 • 21 citations

Induction Treatment with Rabbit Antithymocyte Globulin versus Basiliximab in Renal Transplant Recipients with Planned Early Steroid Withdrawal

2011 • 21 citations

Anti-Thymocyte Globulin (Thymoglobulin), Tacrolimus, and Sirolimus as Acute Graft-versus-Host Disease Prophylaxis for Unrelated Hematopoietic Stem Cell Transplantation

2012 • 21 citations

Thymoglobulin Induction Dosing Strategies in a Low-Risk Kidney Transplant Population: Three or Four Days?

2010 • 20 citations

Effectiveness and safety of rabbit anti-thymocyte globulin in Japanese patients with aplastic anemia

2013 • 19 citations

Induction With and Without Antithymocyte Globulin Combined With Cyclosporine/Tacrolimus-Based Immunosuppression in Renal Transplantation: A Meta-analysis of Randomized Controlled Trials

2009 • 19 citations

Management of acquired aplastic anemia in children

2013 • 19 citations

Intestine and multivisceral transplantation in the United States: a report of 20-year national registry data (1990-2009).

2009 • 19 citations

Single-dose thymoglobulin induction in living-donor renal transplantation

2011 • 18 citations

Incidences of preformed and de novo donor-specific HLA antibodies and their clinicohistological correlates in the early course of kidney transplantation.

2012 • 18 citations

Advances in umbilical cord transplantation: the role of thymoglobulin/ATG in cord blood transplantation

2010 • 18 citations

Evaluating Safety and Efficacy of Rabbit Antithymocyte Globulin Induction in Elderly Kidney Transplant Recipients

2013 • 17 citations

Rabbit ATG for aplastic anaemia treatment: a backward step?

2011 • 17 citations

Initial Immunosuppression in Liver Transplant Recipients With Impaired Renal Function

2005 • 17 citations

Comparison of Long-Term Effect of Thymoglobulin Treatment in Patients With a High Risk of Delayed Graft Function

2012 • 17 citations

Altering the course of type 1 diabetes: an update on prevention and new-onset clinical trials

2013 • 16 citations

Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation

2007 • 16 citations

A decade of experience with a single dose of rabbit antithymocyte globulin or alemtuzumab pretreatment for intestinal and multivisceral transplantation.

2012 • 16 citations

Immunosuppression With Antithymocyte Globulin in Renal Transplantation: Better Long-Term Graft Survival

2005 • 16 citations

RABBIT ANTITHYMOCYTE GLOBULIN AS INDUCTION IMMUNOTHERAPY FOR PEDIATRIC DECEASED DONOR KIDNEY TRANSPLANTATION

2005 • 15 citations

Decreased Incidence of Acute Rejection in Adolescent Kidney Transplant Recipients Using Antithymocyte Induction and Triple Immunosuppression

2007 • 15 citations

Antithymocyte Globulin Induction Therapy in Hepatitis C–Positive Liver Transplant Recipients

2005 • 15 citations

Preliminary results with early corticosteroid withdrawal in African American renal allograft recipients

2005 • 14 citations

Efficacy of Interferon Based Antiviral Therapy for Recurrent Hepatitis C in Patients Who Received Steroid Free Immunosuppression for Liver Transplantation

2008 • 14 citations

Clinical and economic analysis of short-course versus standard-course antithymocyte globulin (rabbit) induction therapy in deceased-donor renal transplant recipients

2011 • 14 citations

Low incidence of graft arteriosclerosis after cardiac transplantation: risk factor analysis for patients with induction therapy

2002 • 14 citations

Efficacy and safety of induction therapy with rabbit antithymocyte globulins in liver transplantation for hepatitis C

2004 • 14 citations

Influence of Polyclonal Antithymocyte Globulins on the Expression of Adhesion Molecules of Isolated Human Umbilical Vein Endothelial Cells

2010 • 12 citations

Calcineurin Inhibitor–Free Monotherapy in Human Leukocyte Antigen–Identical Live Donor Renal Transplantation

2010 • 12 citations

Antithymocyte Globulin Induction Therapy in Heart Transplantation: Prospective Randomized Study of High vs Standard Dosage

2010 • 11 citations

Effects of Antibody Induction on Transplant Outcomes in Human Leukocyte Antigen Zero-Mismatch Deceased Donor Kidney Recipients

2012 • 11 citations

Influence of FcγRIIIA genetic polymorphism on T-lymphocyte depletion induced by rabbit antithymocyte globulins in kidney transplant patients

2013 • 11 citations

Single center experience with thymoglobulin in renal transplantation

1997 • 10 citations

The current trend of induction and maintenance treatment in patient of different PRA levels: a report on OPTN/UNOS Kidney Transplant Registry data.

2010 • 9 citations

Insidious transmission of membranous nephropathy from kidney donor with no clinical manifestations before and after transplantation

2008 • 8 citations

Timing of rabbit antithymocyte globulin induction therapy in kidney transplantation: an observational cohort study

2014 • 7 citations

A <scp>CD</scp>3+ count‐based thymoglobulin induction regimen permits delayed introduction of calcineurin inhibitors in kidney transplantation

2012 • 6 citations

Retreatment by antithymocyte globulin for second kidney transplantation: Efficacy, tolerance and safety

2012 • 5 citations

Comparison Between Thymoglobulin and ATGAM as an Induction Agent in Adult Kidney Transplantation: A Single-Center Experience

2012 • 5 citations

The DGFS: a Useful Scoring System for the Prediction and Management of Delayed Graft Function Following Kidney Transplantation From Cadaveric Donors.

2014 • 1 citations

Induction therapy with antithymocyte globulin reduces the incidence of allograft rejection and improves graft survival in cadaver renal transplantation.

1993 • 1 citations

Rabbit Antithymocyte Globulin Induction Therapy Induces Expansion of HeliosnegFoxp3pos Regulatory T Cells in Kidney Transplant Patients

2012 • 1 citations

Rabbit Antithymocyte Globulin Induction Therapy Induces Donor-Specific Helios(neg)FOXP3(pos) Regulatory T Cells in Kidney Transplant Patients.

2013 • 1 citations

Clinical outcome in heart transplant recipients with chronic kidney disease receiving thymoglobin for induction therapy

2013 • 1 citations